T0	Participants 0 70	Risperidone dosing in children and adolescents with autistic disorder:
T1	Participants 175 212	children and adolescents with autism.
T2	Participants 213 242	Patients (N = 96; 5-17 years)
T3	Participants 766 801	significantly only in the high-dose
T4	Participants 893 932	more frequently in high-versus low-dose